Hepatic Encephalopathy: Pathophysiology and Treatment: Experimental Biology and Medicine, cartea 22
Autor Roger F. Butterworth, Gilles Pomier Layrarguesen Limba Engleză Hardback – 30 oct 1989
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1343.58 lei 6-8 săpt. | |
Humana Press Inc. – 17 sep 2011 | 1343.58 lei 6-8 săpt. | |
Hardback (1) | 1192.49 lei 6-8 săpt. | |
Humana Press Inc. – 30 oct 1989 | 1192.49 lei 6-8 săpt. |
Din seria Experimental Biology and Medicine
- 15% Preț: 630.02 lei
- 5% Preț: 710.29 lei
- 5% Preț: 1379.65 lei
- 5% Preț: 1376.11 lei
- 5% Preț: 699.75 lei
- 18% Preț: 1195.09 lei
- 5% Preț: 1381.39 lei
- 18% Preț: 1178.80 lei
- 5% Preț: 692.37 lei
- 5% Preț: 1368.71 lei
- 18% Preț: 1169.26 lei
- 18% Preț: 1192.65 lei
- 5% Preț: 1369.95 lei
- 18% Preț: 1176.12 lei
- 5% Preț: 699.95 lei
- 5% Preț: 1070.53 lei
- 5% Preț: 756.56 lei
- 5% Preț: 1369.95 lei
- 5% Preț: 702.23 lei
- 18% Preț: 922.82 lei
- 18% Preț: 1189.61 lei
- 5% Preț: 1071.42 lei
- 15% Preț: 619.80 lei
- 18% Preț: 1193.86 lei
Preț: 1192.49 lei
Preț vechi: 1454.25 lei
-18% Nou
Puncte Express: 1789
Preț estimativ în valută:
228.23€ • 240.77$ • 190.19£
228.23€ • 240.77$ • 190.19£
Carte tipărită la comandă
Livrare economică 03-17 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780896031647
ISBN-10: 0896031640
Pagini: 622
Ilustrații: XX, 622 p.
Dimensiuni: 155 x 235 x 35 mm
Greutate: 1.07 kg
Ediția:1989
Editura: Humana Press Inc.
Colecția Humana
Seria Experimental Biology and Medicine
Locul publicării:Totowa, NJ, United States
ISBN-10: 0896031640
Pagini: 622
Ilustrații: XX, 622 p.
Dimensiuni: 155 x 235 x 35 mm
Greutate: 1.07 kg
Ediția:1989
Editura: Humana Press Inc.
Colecția Humana
Seria Experimental Biology and Medicine
Locul publicării:Totowa, NJ, United States
Public țintă
ResearchCuprins
A. Introduction.- Hepatic Encephalopathy: The Present and the Future,.- B. Pathophysiology of Hepatic Encephalopathy.- The Role of Ammonia and Other Toxins.- Ammonia in Liver and Extrahepatic Tissues: An Overview of Metabolism and Toxicity in Mammals,.- Neurophysiology of Ammonia Intoxication,.- Effect of Portacaval Anastomosis on Ammonia Metabolism in Brain and Liver,.- Selective Inhibition of Mitochondrial Dehydrogenases by Ammonia and Fatty Acyl Coenzyme A Derivatives,.- Acute Action of Ammonia on Leucine Metabolism in Isolated Astrocytes, Neurons, and Oligo Cells of Rat Brain,.- Progressive Hyperammonemia and Insulin Resistance After Portacaval Shunt in Homozygous Familial Hypercholesterolemia,.- Mesenteric Venous Stenosis Reduces Hyperammonemia in the Portacaval Shunted Rat,.- Hyperammonemic Encephalopathy Syndrome Due to Urinary Bladder Distention and Infection.- Role of Toxins and Synergism in Hepatic Encephalopathy,.- Cerebral Metabolism and Function in Hepatic Failure.- Brain Energy Metabolism in Hepatic Encephalopathy.- In Vivo NMR Spectroscopy Studies of Cerebral Metabolism in Rats After Portacaval Shunting,.- Effects of Hypercarbia and Portacaval Shunting on Amino Acids and High Energy Phosphates of the Rat Brain: a 1H and 31P NMR Study,.- Positron-Emission Tomography in the Study of Hepatic Encephalopathy,.- The Use of Cultured Astrocytes in the Study of Hepatic Encephalopathy,.- Brain Edema in Experimental Fulminant Hepatic Failure,.- Encephalopathy of Reye’s Syndrome: Studies of the Pathogenic Process in Animal Models,.- The Rat with Carbon Tetrachloride-Induced Cirrhosis as a Model of Hepatic Encephalopathy,.- GABA and Benzodiazepine Receptors in Hepatic Encephalopathy.- Hepatic Encephalopathy and Benzodiazepine Receptor Ligands,.- Detection andCharacterization of Endogenous Benzodiazepine Activity in Both Animal Models and Humans with Hepatic Encephalopathy,.- Isolated CNS Neurons from a Model of Hepatic Encephalopathy Exhibit Increased Sensitivity to a Benzodiazepine,.- Studies of Central and “Peripheral-Type” Benzodiazepine Receptors in Autopsied Brain Tissue from Cirrhotic Patients with Hepatic Encephalopathy,.- Ro 15–1788 Kinetics are Markedly Impaired in Cirrhotic Patients,.- Plasma GABA-like Factor in Hepatic Encephalopathy May Be Taurine,.- Diazepam Metabolism in Perfused Cultures of Adult Rat Hepatocytes,.- Other Neurotransmitter Systems (amines, amino acids, peptides) in Hepatic Encephalopathy.- Hepatocerebral Dysfunction and Brain Serotonin,.- Biogenic Amines in Hepatic Encephalopathy: Evidence for Increased Serotonin Turnover in Human Brain,.- Increased Serotoninergic and Noradrenergic Activity in an Experimental Model of Hepatic Encephalopathy in Rats,.- Excitatory Amino Acids and Hepatic Encephalopathy,.- Activities of Glutamate-Related Enzymes in Autopsied Brain Tissue from Cirrhotic Patients with Hepatic Encephalopathy,.- Does Ammonia Exert its Neurotoxicity Through an Inhibition of Transmitter Glutamate Synthesis?.- Beta-Endorphin and Opiate Receptor Changes in Acute and Chronic Models of Hepatic Encephalopathy,.- C. Treatment of Hepatic Encephalopathy.- Update of Existing Therapeutic Approaches.- Treatment of Hepatic Encephalopathy. New Perspectives on Old Ideas,.- Treatment of Hepatic Encephalopathy with Lactulose and Antibiotics,.- Nutritional Therapy of Portal-Systemic Encephalopathy: The Branched-Chain Amino Acid Story,.- Nutrition, Diet, and Hepatic Encephalopathy,.- Partial Portal Decompression: Initial Clinical Experience with Small-Stoma Portacaval Shunt,.- PotentialTherapeutic Use of Benzodiazepine Antagonists.- Benzodiazepine-Antagonist (Ro 15–1788) Flumazenil, Anexate®, Pharmacokinetics, and Therapeutic Applications,.- Effects of the Benzodiazepine Antagonist Flumazenil in Hepatic Encephalopathy in Man,.- Treatment of Hepatic Encephalopathy with the Benzodiazepine Antagonist Flumazenil.